The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards published within provide a scientific basis for quality control during the entire life cycle of a product.
These standards are legally binding – as laid down in the Council of Europe’s Convention on the elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all signatory member states of the Convention.
- The Pharmacopoeia you need to comply with in order to market your products in 38 European countries and beyond.
- It delivers crucial information earlier than any other pharmacopoeia.
- With 114 new and 683 revised texts, approximately 30% of the content is new or revised compared to Edition 9.0.
- It contains 2 420 monographs, 374 general texts (including general monographs and methods of analysis) and around2 780 descriptions of reagents.
- Print version: the 10th Edition consists of 3 initial volumes (10.0) complemented by 8 non-cumulative supplements (10.1 to 10.8). For the convenience of users, direct access to complementary information (Knowledge Database) is included for each monograph and general chapters through a data matrix code. Available in either English or French, the print version contains a subscription key (EPID code) that allows access to online archives.
- 10th Edition print version: the 2020 subscription will consist of the first 3 volumes (10.0) and the first 2 non-cumulative updates, 10.1 and 10.2, and will provide access to the Ph. Eur. online archives until 31 December 2020.